Efficacy of Shiatsu in Individuals With Fibromyalgia: a Randomized Clinical Trial

November 14, 2012 updated by: Susan Yuan, University of Sao Paulo General Hospital

Efficacy of Shiatsu in Pain, Flexibility, Sleep, Anxiety and Quality of Life in Individuals With Fibromyalgia: a Randomized Clinical Trial

Fibromyalgia is a syndrome characterized by chronic and generalized musculoskeletal pain and tenderness in tender points. Its etiology and physiopathology are not well known; therefore its treatment is not satisfactory. Having this in view, a search for alternative and complementary medicine has been going on. This kind of practice is under pressure to present evidences of efficacy. A randomized clinical trial will be carried out with the aim of verifying the efficacy of a massage technique called Shiatsu in the improvement of pain, flexibility, quality of sleep, anxiety and quality of life of individuals with fibromyalgia. A sample of 34 subjects will be divided in Shiatsu Group and Control Group. All subjects will be evaluated in the beginning, in the middle and at the end of the treatment. Pain will be evaluated by the following instruments: visual analogue scale (VAS) and dolorimetry. The V-sit and reach test (VSRT) will be used to assess the flexibility of the hamstring muscles and lower back. The sleep will be evaluated with the Pittsburgh Sleep Quality Index (PSQI). The State-Trait Anxiety Inventory (STAI) will be used to evaluate anxiety. The evaluation of quality of life will be made with two instruments: fibromyalgia impact questionnaire (FIQ) and Activities-specific Balance Confidence (ABC) scale. In each treatment session, the subjects will be globally evaluated in the 14 main meridians and their respective points by touch, identifying points of excessive energy and their severity. The Control Group will wait for treatment and remain only with conventional pharmacological treatment, while the Shiatsu Group will receive a treatment with Shiatsu during eight weeks. The results will be expressed in mean and standard deviation. The normality of the data will be verified by the Shapiro-Wilk test. In the intragroup analysis, the T-test for the parametric data and the Wilcoxon test for the nonparametric data. In the comparison between groups, the analysis of variance (ANOVA) test will be used. The level of significance adopted will be α < 0.05.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

In the VAS, the subject marks the intensity of its pain in a 10 centimeter horizontal line.

In dolorimetry, the pain thresholds (PT) of 18 tender points are measured with the dolorimeter.

The VSRT assesses the flexibility mainly of the hamstring muscles and also of the lower back.

The PSQI is constituted of 19 questions. Scores of five or more indicate bad sleep quality and sleep disturbances.

The STAI is composed of two scales of items with semantic content which expresses the absence or presence of anxiety. Higher scores obtained in each scale indicate higher levels of anxiety.

The FIQ is composed of ten items. Higher scores indicate higher impact of fibromyalgia over quality of life The ABC scale was translated and adapted for this study and consists of a 17-item scale in which the level of confidence in balance is indicated in the execution of diverse activities.

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sao Paulo, Brazil, 05403-010
        • University of Sao Paulo General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

26 years to 56 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • diagnoses of fibromyalgia

Exclusion Criteria:

  • diagnoses of diseases that cause chronic pain
  • skin lesions and infection
  • pregnancy
  • two consecutive absences in treatment sessions
  • use of psychotherapy, physiotherapy or complementary therapies in the last 6 months
  • regular supervised physical activity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Experimental: Shiatsu Group
8-week treatment with two Shiatsu sessions per week (50-minute duration)
Other Names:
  • Acupressure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in VAS at 8 weeks
Time Frame: baseline and 8 weeks
In the VAS the subject marks the intensity of its pain in a 10 centimeter horizontal line
baseline and 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in FIQ at 4 weeks
Time Frame: baseline and 4 weeks
The FIQ is composed of ten items, in which higher scores indicate higher impact of fibromyalgia over quality of life
baseline and 4 weeks
Change from baseline in PSQI at 4 weeks
Time Frame: baseline and 4 weeks
The sleep will be evaluated with the PSQI, which is constituted of 19 questions. Scores of five or more indicate bad sleep quality and sleep disturbances.
baseline and 4 weeks
Change from baseline in STAI at 4 weeks
Time Frame: baseline and 4 weeks
The STAI will be used to evaluate anxiety. It is composed of two scales of items with semantic content which expresses the absence or presence of anxiety. Higher scores indicate higher levels of anxiety.
baseline and 4 weeks
Change from baseline in VSRT at 4 weeks
Time Frame: baseline and 4 weeks
The VSRT will be used to assess the flexibility mainly of the hamstring muscles and also of the lower back.
baseline and 4 weeks
Change from baseline in FIQ at 8 weeks
Time Frame: baseline and 8 weeks
The FIQ is composed of ten items, in which higher scores indicate higher impact of fibromyalgia over quality of life.
baseline and 8 weeks
Change from baseline in PSQI at 8 weeks
Time Frame: baseline and 8 weeks
The sleep will be evaluated with the PSQI, which is constituted of 19 questions. Scores of five or more indicate bad sleep quality and sleep disturbances.
baseline and 8 weeks
Change from baseline in STAI at 8 weeks
Time Frame: baseline and 8 weeks
The STAI will be used to evaluate anxiety. It is composed of two scales of items with semantic content which expresses the absence or presence of anxiety. Higher scores indicate higher levels of anxiety.
baseline and 8 weeks
Change from baseline in VSRT at 8 weeks
Time Frame: baseline and 8 weeks
The VSRT will be used to assess the flexibility mainly of the hamstring muscles and also of the lower back.
baseline and 8 weeks
Change from baseline in VAS at 4 weeks
Time Frame: Baseline and 4 weeks
In the VAS, the subject marks the intensity of its pain in a 10 centimeter horizontal line.
Baseline and 4 weeks
Change from baseline in ABC scale at 4 weeks
Time Frame: baseline and 4 weeks
The ABC scale was translated and adapted for this study and consists of a 17-item scale in which the level of confidence in balance is indicated in the execution of diverse activities.
baseline and 4 weeks
Change from baseline in ABC scale at 8 weeks
Time Frame: baseline and 8 weeks
The ABC scale was translated and adapted for this study and consists of a 17-item scale in which the level of confidence in balance is indicated in the execution of diverse activities.
baseline and 8 weeks
Change from baseline in PT mean at 4 weeks
Time Frame: baseline and 4 weeks
In dolorimetry, the PT of 18 tender points are measured with the dolorimeter. Then the PT mean will be calculated.
baseline and 4 weeks
Change from baseline in PT mean at 8 weeks
Time Frame: baseline and 8 weeks
In dolorimetry, the PT of 18 tender points are measured with the dolorimeter. Then the PT mean will be calculated.
baseline and 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Susan LK Yuan, MSc, Faculty of Medicine of the University of São Paulo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2010

Primary Completion (Actual)

November 1, 2011

Study Completion (Actual)

November 1, 2011

Study Registration Dates

First Submitted

January 27, 2011

First Submitted That Met QC Criteria

February 4, 2011

First Posted (Estimate)

February 7, 2011

Study Record Updates

Last Update Posted (Estimate)

November 15, 2012

Last Update Submitted That Met QC Criteria

November 14, 2012

Last Verified

November 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fibromyalgia

Clinical Trials on Shiatsu

Subscribe